Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 01, 2019
GVK BIO and BE Pharmaceuticals announced a strategic collaboration in drug product development.
read more
Tuesday, October 04, 2016
Ajinomoto Althea, Inc. (“Althea”) announced that a biologics candidate developed by a Japanese global pharmaceutical company and manufactured at Ajinomoto Althea using CORYNEX® Protein Expression System, has entered phase I clinical trials.
read more
Tuesday, January 07, 2020
Biologics Consulting announced Kenneth P. Guito, MBA was hired as its COO following a 35-year career in the Biotech/Biopharmaceutical Industry.
read more
Wednesday, April 20, 2016
Biologics Consulting, a full-service regulatory and product development consulting firm for biologics, pharmaceuticals and medical devices, has announced the launch of its Clinical Trials Planning and Oversight Group.
read more
Brazil's National Health Surveillance Agency has qualified Axis Biotec manufacturing facility in Rio de Janeiro to register, import, manufacture and also store and distribute biologic drugs in Brazil.
read more
Biologics, Inc. has been selected by AstraZeneca as a specialty pharmacy provider for IRESSA® (gefitinib). IRESSA® was approved by the FDA on July 13, 2015, for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC).
read more
Biologos announced the appointment of Hetal Patel as Chief Executive Officer. The announcement coincides with Biologos’ 50th anniversary and follows significant recent investments in facilities and capabilities to support customers across biopharma, ...
read more
Biolojic Design has entered into a research collaboration and license option agreement with Nektar to discover and develop agonistic antibodies.
read more
Thursday, November 18, 2021
Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced that portfolio company BioMagnetic Solutions (BMS) has signed a lease with GLP Development to build a cGMP-grade production facility in Innovation ...
read more
Wednesday, October 17, 2018
BioMarin announced the company earned $15 million in milestone payments from Pfizer.
read more
BioMarin announced that the company received $20 million in milestone payments from Pfizer.
read more
The company announced its successful approval by the FDA for the manufacturing, testing and release of recombinant Cas9 nuclease from its headquarters site. Cas9 is an essential component of CRISPR-based gene editing therapies, including CASGEVY® (...
read more
Wednesday, November 11, 2020
German independent research institute BioMed X has expanded its immunology research program with Janssen Research & Development.
read more
Tuesday, January 06, 2015
Timothy Callahan, Ph.D., chief medical officer of Biomedical Systems, a premier, global provider of centralized diagnostic services, spoke on “Cardiac Safety in the Post E14 Era” at a recent seminar in Suzhou, China.
read more
Monday, December 28, 2020
BioMedion has announced the acquisition of the Compliance Division of arivis AG, a provider of regulatory software and biomedical 3D and big image data software solutions.
read more